1. Beneficial action of resveratrol: How and why?
   Gustavo Tomas Diaz-Gerevini et al, 2016, Nutrition CrossRef
2. Application of Lycium Barbarum Polysaccharide Liposome Nanoparticles to Improve the Slow Healing of Refractory Wounds in Diabetic Foot
   Fan Gong et al, 2024, Journal of Biomedical Nanotechnology CrossRef
3. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
   Zhidong Wang et al, 2016, Tumor Biology CrossRef
4. Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells
   Murali Subramani et al, 2017, Scientific Reports CrossRef
5. Resveratrol and the Human Retina
   Adela Pintea et al, 2019, Handbook of Nutrition, Diet, and the Eye CrossRef
6. Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
   Wamidh H. Talib et al, 2020, Molecules CrossRef
7. Polyphenols and Posterior Segment Eye Diseases: Effects on Angiogenesis, Invasion, Migration and Epithelial-Mesenchymal Transition
   Miłosz Caban et al, 2023, Food Reviews International CrossRef
8. Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
   Catharina Busch et al, 2017, Frontiers in Immunology CrossRef
9. The Role of Resveratrol in Cancer Therapy
   Jeong-Hyeon Ko et al, 2017, International Journal of Molecular Sciences CrossRef
10. RPE and the Vascular Endothelial Growth Factor
    Alexa Karina Klettner, 2020, Retinal Pigment Epithelium in Health and Disease CrossRef
11. Molecular Basis of the Beneficial Actions of Resveratrol
    Gastón Repossi et al, 2020, Archives of Medical Research CrossRef
12. Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA Pathway
    Fang Zhu et al, 2021, Frontiers in Pharmacology CrossRef
13. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway
    Yin-Gi Jang et al, 2019, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
14. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs
    Cheng-Cheng Shen et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
15. VEGF-R2/Caveolin-1 Pathway of Undifferentiated ARPE-19 Retina Cells: A Potential Target as Anti-VEGF-A Therapy in Wet AMD by Resvega, an Omega-3/Polyphenol Combination
    Flavie Courtaut et al, 2021, International Journal of Molecular Sciences CrossRef
16. Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study
    Hussam Aly Sayed Murad et al, 2022, BMC Complementary Medicine and Therapies CrossRef
17. RPE und der vaskuläre endotheliale Wachstumsfaktor (VEGF)
    Alexa Karina Klettner, 2024, Das Retinale Pigmentepithel – Physiologie und Pathologie CrossRef
18. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
    Weiqiang Zhou et al, 2019, Current Medicinal Chemistry CrossRef
19. Resveratrol: Its Path from Isolation to Therapeutic Action in Eye Diseases
    Roxana Pop et al, 2022, Antioxidants CrossRef
20. Protective effects of resveratrol improve cardiovascular function in rats with diabetes
    Fuqin Yan et al, 2017, Experimental and Therapeutic Medicine CrossRef
21. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy
    Agnieszka Synowiec et al, 2023, International Journal of Molecular Sciences CrossRef
22. Differential Effects of Resveratrol on HECa10 and ARPE-19 Cells
    Monika Leśniak et al, 2022, Applied Sciences CrossRef